Deficiencies of different MMR genes showed cancer-specific immune response, and we further showed in a murine model of hepatocellular carcinoma that MLH1 knockout combined with forced expression of tumor neoantigens improved the survival of mice. This evidence concerns the gene MLH1 and hepatocellular carcinoma.